Harmony Biosciences Holdings Inc (HRMY)
34.07
+0.84
(+2.53%)
USD |
NASDAQ |
Nov 22, 16:00
34.07
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap: 1.943B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.943B |
| November 21, 2024 | 1.895B |
| November 20, 2024 | 1.870B |
| November 19, 2024 | 1.852B |
| November 18, 2024 | 1.886B |
| November 15, 2024 | 1.894B |
| November 14, 2024 | 1.882B |
| November 13, 2024 | 1.930B |
| November 12, 2024 | 2.001B |
| November 11, 2024 | 2.048B |
| November 08, 2024 | 2.058B |
| November 07, 2024 | 1.991B |
| November 06, 2024 | 1.956B |
| November 05, 2024 | 1.905B |
| November 04, 2024 | 1.885B |
| November 01, 2024 | 1.887B |
| October 31, 2024 | 1.832B |
| October 30, 2024 | 1.928B |
| October 29, 2024 | 2.366B |
| October 28, 2024 | 2.039B |
| October 25, 2024 | 1.968B |
| October 24, 2024 | 1.942B |
| October 23, 2024 | 1.942B |
| October 22, 2024 | 1.988B |
| October 21, 2024 | 1.993B |
| Date | Value |
|---|---|
| October 18, 2024 | 2.019B |
| October 17, 2024 | 1.994B |
| October 16, 2024 | 1.987B |
| October 15, 2024 | 2.025B |
| October 14, 2024 | 2.023B |
| October 11, 2024 | 1.986B |
| October 10, 2024 | 1.985B |
| October 09, 2024 | 1.916B |
| October 08, 2024 | 1.982B |
| October 07, 2024 | 1.961B |
| October 04, 2024 | 1.973B |
| October 03, 2024 | 1.983B |
| October 02, 2024 | 2.029B |
| October 01, 2024 | 2.238B |
| September 30, 2024 | 2.281B |
| September 27, 2024 | 2.224B |
| September 26, 2024 | 2.261B |
| September 25, 2024 | 2.119B |
| September 24, 2024 | 2.149B |
| September 23, 2024 | 2.174B |
| September 20, 2024 | 2.233B |
| September 19, 2024 | 2.216B |
| September 18, 2024 | 2.179B |
| September 17, 2024 | 2.206B |
| September 16, 2024 | 2.203B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.125B
Minimum
Oct 27 2023
3.613B
Maximum
Dec 05 2022
2.208B
Average
2.103B
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 81.10B |
| Incyte Corp | 13.82B |
| EyePoint Pharmaceuticals Inc | 610.85M |
| Cassava Sciences Inc | 1.274B |
| Capricor Therapeutics Inc | 846.65M |
Market Cap Related Metrics
| PE Ratio | 16.15 |
| PS Ratio | 2.899 |
| Price to Book Value | 3.256 |
| Price to Free Cash Flow | 8.977 |
| Price | 34.07 |
| Earnings Yield | 6.19% |
| Operating PE Ratio | 11.28 |
| Normalized PE Ratio | 16.15 |